MED29 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), AS-tDR-007333 is a novel oncogenic tRF that activates mediator of RNA polymerase II transcription subunit 29 (MED29) through two distinct mechanisms to promote NSCLC cell malignancy.